Dysregulation of the splicing machinery is associated to the development of non-alcoholic fatty liver disease (Supplementary Information).pdf

Supplemental Information from:Dysregulation of the splicing machinery is associated to the development of non-alcoholic fatty liver disease.Mercedes del Río-Moreno, MS^1,2,3,4, Emilia Alors-Pérez, MS^1,2,3,4, Sandra González-Rubio, PhD^1,3,5, Gustavo Ferrín, PhD^1,3,5, Oscar Reyes, PhD^1,6, Manuel Rodríguez-Perálvarez, MD PhD^1,3,5, Marina E. Sánchez-Frías, MD PhD^1,3,7, Rafael Sánchez-Sánchez, MD^1,3,7, Sebastián Ventura, PhD^1,6,8, José López-Miranda, MD^1,3,4,9, Rhonda D. Kineman, PhD¹⁰, Manuel de la Mata, MD^1,3,5, Justo P. Castaño, PhD^1,2,3,4, Manuel D. Gahete, PhD^1,2,3,4*, Raúl M. Luque, PhD^1,2,3,4*. ¹Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain. ²Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain. ³Reina Sofia University Hospital, Córdoba, Spain. ⁴CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain. ⁵CIBER Digestive and Liver Diseases (CIBERehd), Córdoba, Spain. ⁶Department of Computer Sciences, University of Cordoba, Cordoba, Spain. ⁷Anatomical Pathology Service, Reina Sofia University Hospital (HURS), Cordoba, Spain. ⁸Department of Information Systems, King Abdulaziz University, Saudi Arabia Kingdom. ⁹Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, Córdoba, Spain. ¹⁰Research and Development Division, Jesse Brown Veterans Affairs Medical Center; Section of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA. *These authors should be considered as corresponding authors.